Farxiga (dapagliflozin) is primarily used to treat type 2 diabetes by improving blood sugar levels alongside diet and exercise. It is also prescribed to reduce the risk of hospitalization for heart failure, lower the risk of cardiovascular death, and prevent worsening kidney disease in adults with chronic kidney disease or heart failure. Farxiga works by helping the kidneys remove excess sugar, sodium, and fluid from the body, which helps lower blood sugar, reduce blood pressure, and decrease stress on the heart and kidneys.
Main Uses of Farxiga
- Improves blood sugar control in adults with type 2 diabetes.
- Reduces the risk of hospitalization or urgent medical visits for heart failure.
- Lowers the risk of cardiovascular death in people with heart failure.
- Prevents worsening kidney function in people with chronic kidney disease.
How Farxiga Works
Farxiga belongs to the class of drugs called SGLT2 inhibitors, which block glucose reabsorption in the kidneys, causing excess glucose to be eliminated through urine. This process also helps reduce sodium and fluid retention, which helps reduce heart strain and lowers blood pressure.
Farxiga is not used to treat type 1 diabetes or diabetic ketoacidosis and is prescribed under medical supervision for specific conditions related to diabetes, heart failure, and kidney disease.
